Selective &bgr;3 adrenergic agonists
US6686372B2 · kind B2 · utility
0Cited by
42References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2002 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | Apr 10, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective &bgr;3 receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and methods of treating type II diabetes and obesity, comprising administering to a mammal in need thereof compounds of the Formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.